Nobilis Health Corp.
NRTSF · OTC
6/30/2018 | 3/31/2018 | 12/31/2017 | 9/30/2017 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.3% | -25.7% | 34.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.4% | 59.4% | 64.9% | 59.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 13.5% | 5.8% | 23.8% | 6.3% |
| Net Income | $0 | -$0 | $0 | $0 |
| % Margin | 1.3% | -6% | 4.1% | 1.6% |
| EPS Diluted | 0.01 | -0.049 | 0.05 | 0.01 |
| % Growth | 120.3% | -198.6% | 400% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |